2018 Annual Meeting | N4 - Neuroscience in the Clinic: Opioid Use and Abuse: The Overlapping Neurobiology of Pain and Addiction, and the Path Toward Better Treatments

Date Wednesday 04/25/18

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Neuroscience in the Clinic Session

Director(s) Jessica Robinson Papp, MD, FAAN, Walter J. Koroshetz, MD, FAAN

Topic(s) Pain

Learning Objectives Participants will become familiar with central nervous system mechanisms underlying chronic pain and addiction and how knowledge of these mechanisms can inform drug discovery. Participants will also understand changes in public policy which effect neurologists and their patients with chronic pain, with a focus on the U.S. National Pain Strategy.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Interactive

Event Timeline
03:30 PM - 03:35 PM	Luncheon	Introduction Jessica Robinson Papp, MD, FAAN
03:30 PM - 05:30 PM	Abstract	001 - Association of OPRM1, OPRK1 and COMT genes with opioid response is opioid and pain modality specific Kwo Wei David Ho, MD, PhD
03:30 PM - 05:30 PM	Abstract	002 - Provider Perspectives On Patient-Provider Communication Related to Opioid Use for Chronic Pain Allison P. Navis, MD
03:35 PM - 03:50 PM	Speaker	Patient Presentation: Use of Opioids in Complex Disease Elyse J. Singer, MD
03:50 PM - 04:10 PM	Speaker	Neurobiology of Pain and Addiction Catherine Cahill
04:10 PM - 04:30 PM	Speaker	N4.001: Association of OPRM1, OPRK1 and COMT genes with opioid response is opioid and pain modality specific Kwo Wei David Ho, MD, PhD
04:25 PM - 04:40 PM	Speaker	Clinical Follow-up and Discussion of National Pain Strategy Walter J. Koroshetz, MD, FAAN
04:40 PM - 04:55 PM	Speaker	N4.002: Provider Perspectives On Patient-Provider Communication Related to Opioid Use for Chronic Pain Allison P. Navis, MD
04:55 PM - 05:10 PM	Speaker	Scientific Wrap-up and Link to Therapeutics Jessica Robinson Papp, MD, FAAN
05:10 PM - 05:30 PM	Q&A	Panel Discussion, Questions and Answers, and Closing Remarks

Faculty Disclosures
Jessica Robinson Papp, MD, FAAN	Dr. Robinson Papp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Immgenuity Inc. Dr. Robinson Papp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropathix Inc. The institution of Dr. Robinson Papp has received research support from NIH. Dr. Robinson Papp has received publishing royalties from a publication relating to health care.
Walter J. Koroshetz, MD, FAAN	Dr. Koroshetz has nothing to disclose.
Elyse J. Singer, MD	The institution of Dr. Singer has received research support from NIH. Dr. Singer has received personal compensation in the range of $1,000,000+ for serving as a Principal investigator/Study section with NIH.
	No disclosure on file
Catherine Cahill	No disclosure on file
Kwo Wei David Ho, MD, PhD	No disclosure on file
Allison P. Navis, MD	The institution of Dr. Navis has received research support from NIH Loan Repayment Program.
Mary Catherine George, PhD	Ms. George has or had stock in Gnomx. The institution of Ms. George has received research support from Icahn School of Medicine at Mount Sinai. Ms. George has received intellectual property interests from a discovery or technology relating to health care.

��ɫ��

��ɫ��